These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15173012

  • 1. A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE.
    Cancer Res; 2004 Jun 01; 64(11):3987-93. PubMed ID: 15173012
    [Abstract] [Full Text] [Related]

  • 2. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE.
    Oncogene; 2004 Jul 29; 23(34):5834-42. PubMed ID: 15208677
    [Abstract] [Full Text] [Related]

  • 3. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance.
    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE.
    Clin Cancer Res; 2005 May 01; 11(9):3433-8. PubMed ID: 15867245
    [Abstract] [Full Text] [Related]

  • 4. CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Oncogene; 2004 Jan 15; 23(2):465-73. PubMed ID: 14724575
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Clin Cancer Res; 2004 Apr 01; 10(7):2307-18. PubMed ID: 15073106
    [Abstract] [Full Text] [Related]

  • 6. CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS, Ito H, Benoit E, Ashley SW, Whang EE.
    Br J Cancer; 2004 Oct 04; 91(7):1384-90. PubMed ID: 15316565
    [Abstract] [Full Text] [Related]

  • 7. siRNA directed against c-Src enhances pancreatic adenocarcinoma cell gemcitabine chemosensitivity.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    J Am Coll Surg; 2004 Jun 04; 198(6):953-9. PubMed ID: 15194078
    [Abstract] [Full Text] [Related]

  • 8. RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.
    Duxbury MS, Ito H, Benoit E, Zinner MJ, Ashley SW, Whang EE.
    Biochem Biophys Res Commun; 2003 Nov 21; 311(3):786-92. PubMed ID: 14623342
    [Abstract] [Full Text] [Related]

  • 9. CEACAM6 cross-linking induces caveolin-1-dependent, Src-mediated focal adhesion kinase phosphorylation in BxPC3 pancreatic adenocarcinoma cells.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    J Biol Chem; 2004 May 28; 279(22):23176-82. PubMed ID: 15047698
    [Abstract] [Full Text] [Related]

  • 10. c-Src-dependent cross-talk between CEACAM6 and alphavbeta3 integrin enhances pancreatic adenocarcinoma cell adhesion to extracellular matrix components.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):133-41. PubMed ID: 15047158
    [Abstract] [Full Text] [Related]

  • 11. HMGA1 is a molecular determinant of chemoresistance to gemcitabine in pancreatic adenocarcinoma.
    Liau SS, Whang E.
    Clin Cancer Res; 2008 Mar 01; 14(5):1470-7. PubMed ID: 18316571
    [Abstract] [Full Text] [Related]

  • 12. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells.
    Niu W, Liu X, Zhang Z, Xu K, Chen R, Liu E, Wang J, Peng C, Niu J.
    Anticancer Res; 2010 Jan 01; 30(1):135-42. PubMed ID: 20150628
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of oncogenic Pim-3 kinase modulates transformed growth and chemosensitizes pancreatic cancer cells to gemcitabine.
    Xu D, Cobb MG, Gavilano L, Witherspoon SM, Williams D, White CD, Taverna P, Bednarski BK, Kim HJ, Baldwin AS, Baines AT.
    Cancer Biol Ther; 2013 Jun 01; 14(6):492-501. PubMed ID: 23760491
    [Abstract] [Full Text] [Related]

  • 14. CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinoma.
    Duxbury MS, Ito H, Ashley SW, Whang EE.
    Biochem Biophys Res Commun; 2004 May 07; 317(3):837-43. PubMed ID: 15081416
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells.
    Ng SSW, Tsao MS, Chow S, Hedley DW.
    Cancer Res; 2000 Oct 01; 60(19):5451-5. PubMed ID: 11034087
    [Abstract] [Full Text] [Related]

  • 16. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.
    Liau SS, Ashley SW, Whang EE.
    J Gastrointest Surg; 2006 Nov 01; 10(9):1254-62; discussion 1263. PubMed ID: 17114012
    [Abstract] [Full Text] [Related]

  • 17. Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.
    Duxbury MS, Matros E, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Ann Surg; 2004 Oct 01; 240(4):667-74; discussion 675-6. PubMed ID: 15383794
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic effect of anti CEACAM6 monoclonal antibody against lung adenocarcinoma by enhancing anoikis sensitivity.
    Hong KP, Shin MH, Yoon S, Ji GY, Moon YR, Lee OJ, Choi SY, Lee YM, Koo JH, Lee HC, Lee GK, Kim SR, Lee KH, Han HS, Choe KH, Lee KM, Hong JM, Kim SW, Yi JH, Ji HJ, Kim YB, Song HG.
    Biomaterials; 2015 Oct 01; 67():32-41. PubMed ID: 26204223
    [Abstract] [Full Text] [Related]

  • 19. WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells.
    Wei W, Sun HH, Li N, Li HY, Li X, Li Q, Shen XH.
    Hepatobiliary Pancreat Dis Int; 2014 Oct 01; 13(5):529-38. PubMed ID: 25308364
    [Abstract] [Full Text] [Related]

  • 20. The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas.
    Harris JC, Gilliam AD, McKenzie AJ, Evans SA, Grabowska AM, Clarke PA, McWilliams DF, Watson SA.
    Cancer Res; 2004 Aug 15; 64(16):5624-31. PubMed ID: 15313900
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.